Prenatal screens:  Blood type B positive, antibody negative, Rubella immune, RPR nonreactive, hepatitis B surface antigen negative, group beta strep status is negative.
She progressed to a vaginal delivery.
She required vigorous resuscitation with intubation, chest compressions and a total of 5 doses of endotracheal and IV epinephrine.
The infant also had gasping respirations with onset at 10 minutes of age.
All measures 50th to 75th percentile for postnatal age one month.
HOSPITAL COURSE BY SYSTEMS INCLUDING PERTINENT LABORATORY DATA:  Respiratory:  [**Known lastname 46001**] was intubated and on ventilatory support through her first day of life.
Her respiratory effort improved to the point where she was extubated to nasal cannula 02.
Cardiovascular:  [**Known lastname 46001**] was treated with volume expansion and dopamine in the first 12 hours of life.
and maintained on IV fluids.
Enteral feeds were started on day of life 5 and gradually advanced to full volume.
A blood culture was obtained prior to starting ampicillin and Cefotaxime.
The cultures were no growth at 48  hours and the antibiotics were discontinued.
[**Known lastname 72778**] only other infectious disease issues have been oral thrush.
She was initially treated with a 7 day course of oral Nystatin from [**5-21**] through [**2143-5-28**].
On [**2143-6-3**], she was noted once again to have oral thrush and was restarted on Nystatin.
There was not much improvement and on [**2143-6-9**], she was started on Fluconazole.
[**Known lastname 46001**] did not receive any transfusions of blood products.
[**Known lastname 46001**] had difficulty with oral feedings.
On [**2143-5-22**], she had a modified barium swallow which showed that she was aspirating with thin fluids.
Her formula and breast milk were then thickened to nectar-like consistency and she was re-evaluated 2 weeks later with another modified barium swallow, where she was found to be tolerating thin liquids.
In accordance with her parents wishes, we are allowing her a home trial of oral feedings with evaluation for possible gastrostomy tube to be evaluated within the first week.
[**Known lastname 46001**] also had a right brachial plexus injury noted at the time of delivery which resolved over the first 2 weeks of life.
Medications: Fluconazole 16 mg p.o.
Ferrous sulfate 25 mg per ml dilution 0.5 ml p.o.
Simethicone 20 mg p.o.
Tri-Vi-[**Male First Name (un) **] or other multi-vitamin preparation, 1 ml p.o.
Iron and vitamin D supplementation: Iron supplementation is recommended for preterm and low birth weight infants until 12 months corrected age.
All infants fed predominantly breast milk should receive Vitamin D supplementation at 200 IU (may be provided as a multi-vitamin preparation) daily until 12 months corrected age.
Immunizations: Hepatitis B vaccine was administered on [**2143-5-16**].
Immunizations recommended: Synagis RSV prophylaxis should be considered from [**Month (only) **] through [**Month (only) 958**] for infants who meet any of the following four criteria:  (1) Born at less than 32 weeks; (2) Born between 32 weeks and 35 weeks with two of the following:  Day care during RSV season, a smoker in the household, neuromuscular disease, airway abnormalities or school age siblings; (3) chronic lung disease or (4) hemodynamically significant congenital heart disease.
Influenza immunization is recommended annually in the Fall for all infants once they reach 6 months of age.
Before this age, and for the first 24 months of the child's life, immunization against influenza is recommended for household contacts and out-of-home caregivers.
This infant has not received rotavirus vaccine.
